【24h】

Endovascular treatment of unruptured intracranial aneurysms.

机译:颅内动脉瘤的血管内治疗。

获取原文
获取原文并翻译 | 示例
           

摘要

We report the clinical and angiographic results of endovascular treatment of unruptured intracranial aneurysms. Over a three-year period, 80 unruptured aneurysms in 74 patients were electively treated with endovascular management. One aneurysm was diagnosed during investigations for a second ruptured aneurysm, 54 aneurysms were incidentally discovered, 18 aneurysms presented with symptoms of mass effect and seven aneurysms presented with symptoms of brain stem ischemia. Mean size of the 80 unruptured aneurysms was 12.5+/-8.0 mm (range, 2-39 mm). Thirty-six aneurysms (45%) were small (<10 mm), 38 aneurysms (47.5%) were large (10-25 mm), and six aneurysms (7.5%) were giant (25-39 mm). Forty-eight wide-necked aneurysms (60%) were coiled with the aid of a supporting device. The mortality rate was 1.25%, and the overall morbidity was 1.25%. Of these, one of the patients suffered a stroke, leading to severe disability (1.25%). In one patient, the aneurysm ruptured during treatment, resulting in death. Initial aneurysm occlusion was complete (100%) in 76.25% aneurysms, nearly complete (90%-98%) in 10% aneurysms and incomplete (60%-85%) in 13.75% aneurysms. Follow-up angiography was available in 67 patients with 73 treated aneurysms (91.25%) from one to 36 months (mean 9.3 months); partial reopening occurred in 7.5%, mainly large and giant aneurysms (5.5%). Additional coiling was performed in four aneurysms. There were no complications in additional treatments. At 14.1-month clinical follow-up (range, 2 to 36 months), mRS score was 0 in 78.75% patients, 1 in 10% patients, 2 in 8.75% and 3 in 1.25%. There was no aneurysmal rupture during the follow-up period. Endovascular treatment of unruptured intracranial aneurysms has low procedural mortality and morbidity rates.
机译:我们报告了颅内动脉瘤未破裂的血管内治疗的临床和血管造影结果。在三年的时间里,对74例患者中的80例未破裂的动脉瘤进行了血管内治疗。在调查过程中诊断出一个动脉瘤,第二个破裂的动脉瘤被偶然发现,偶然发现了54个动脉瘤,其中18个动脉瘤表现为质量效应,而7个动脉瘤表现为脑干缺血。 80个未破裂动脉瘤的平均大小为12.5 +/- 8.0 mm(范围2-39 mm)。三十六例(45%)的小动脉瘤(<10毫米),三十八例(47.5%)的大动脉瘤(10-25毫米),六例(7.5%)的大动脉瘤(25-39毫米)。借助于支撑装置将四十八个宽颈动脉瘤(60%)盘绕起来。死亡率为1.25%,总发病率为1.25%。其中,一名患者患有中风,导致严重残疾(1.25%)。一名患者在治疗过程中动脉瘤破裂,导致死亡。最初的动脉瘤闭塞在76.25%的动脉瘤中是完全的(100%),在10%的动脉瘤中几乎是完全的(90%-98%),在13.75%的动脉瘤中是不完全的(60%-85%)。 1至36个月(平均9.3个月)对67例73例经治疗的动脉瘤(91.25%)的患者进行了随访血管造影;部分重新开放发生在7.5%,主要是大动脉瘤和大动脉瘤(5.5%)。在四个动脉瘤中进行额外的卷绕。没有其他治疗并发症。在14.1个月的临床随访(范围2到36个月)中,mRS评分在78.75%患者中为0,在10%患者中为1,在8.75%中为2,在1.25%中为3。随访期间无动脉瘤破裂。颅内动脉瘤的血管内治疗具有较低的程序性死亡率和发病率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号